Promoting Angiogenesis Using Immune Cells for Tissue-Engineered Vascular Grafts

Area of Science:

• Biomaterials Science
• Immunology
• Regenerative Medicine

Background:

• Implantable tissue-engineered vascular grafts (TEVGs) elicit host immune responses, involving complex interactions like blood-material contact and inflammation.
• The immune response to TEVGs has dual effects, potentially aiding or hindering angiogenesis and tissue regeneration, with mechanisms not fully understood.

Purpose of the Study:

• To review the role of immune cells, particularly macrophages, in the context of TEVG performance.
• To summarize current strategies for modulating immune cell activity in vascular regeneration.
• To highlight knowledge gaps regarding the temporal dynamics of immune cell subpopulations and their regulatory functions.

Main Methods:

• Literature review focusing on immune cell involvement in TEVG integration.
• Analysis of current approaches for immune modulation in vascular engineering.
• Synthesis of existing data on immune cell functions during angiogenesis and vascular remodeling.

Main Results:

• Immune responses are integral to TEVG success, exhibiting both beneficial and detrimental impacts on vascularization.
• Macrophages play a significant role, but their precise functions and timing require further elucidation.
• Current immune-modulatory strategies offer potential but need refinement.

Conclusions:

• A deeper understanding of specific immune cell contributions, especially macrophages, is essential for optimizing TEVG design.
• Future research should focus on the temporal activity of immune cell subpopulations and identify key regulatory pathways.
• Targeting immune responses holds promise for enhancing TEVG efficacy in vascular repair and regeneration.